News Archives - Page 31 of 31

Posted by CLINUVEL

March 13, 2016

2016 Announcements

1 min read

CLINUVEL placement of A$8.3 million completed successfully

13 March 2016 ** Not for release or distribution in the United...

Posted by CLINUVEL

March 11, 2016

2016 Announcements

1 min read

Request for Trading Halt

11 March 2016 Pursuant to Listing Rule 17.1, Clinuvel Pharmaceuticals Ltd (CUV)...

Posted by CLINUVEL

February 19, 2016

2016 Announcements

1 min read

Appendix 4D and Half Year Report

19 February 2016 Your Directors present their report on the company and...

Posted by CLINUVEL

February 13, 2016

2016 Announcements

1 min read

CLINUVEL brief on European commercialisation

19 February 2016 CLINUVEL Pharmaceuticals Limited (ASX: CUV; XETRA-DAX: UR9; ADR: CLVLY)...

Posted by CLINUVEL

February 10, 2016

2016 Announcements

1 min read

SCENESSE® receives US FDA orphan designation for cutaneous porphyrias

10 February 2016 Clinuvel Pharmaceuticals Limited (ASX: CUV; XETRA-DAX: UR9; ADR: CLVLY)...

Posted by CLINUVEL

February 7, 2016

2016 Announcements

1 min read

Presentation to international porphyria patient group

8 February 2016 Clinuvel Pharmaceuticals Ltd (ASX: CUV; XETRA‐DAX: UR9; ADR: CLVLY)...

Posted by CLINUVEL

January 28, 2016

2016 Announcements

1 min read

Appendix 4C - Q2 FY16

28 January 2016 Enclosed is a copy of the Quarterly report for...

Posted by CLINUVEL

January 25, 2016

2016 Announcements

1 min read

Form 604

25 January 2016 Enclosed is a notice of a change of interest...

Posted by CLINUVEL

January 20, 2016

2016 Announcements

2 min read

CEO Brief - January 20, 2016

20 January 2016 Having both received and provided services within the healthcare...

Posted by CLINUVEL

January 18, 2016

2016 Announcements

1 min read

Form 604

18 January 2016 Enclosed is a notice of change of interests of...